Phytochemistry and Natural Products Cpph403

Total Page:16

File Type:pdf, Size:1020Kb

Phytochemistry and Natural Products Cpph403 PHYTOCHEMISTRY AND NATURAL PRODUCTS CPPH403 Dr. Dima MUHAMMAD 2018-2019 1 -Trease and Evans Pharmacognosy, William C. Evans, Saunders Elsevier, 2009, sixteenth edition., ISBN 978-0 -7020 -2934 9 2- Textbook of pharmacognosy & phytochemistry, Biren Shah & A.K. Seth, Elsevier, 2010, 1st edition, ISBN: 978-81- 312-2298-0 3-Medicinal Natural Products: A Biosynthetic Approach. Paul M Dewick, John Wiley & Sons, 2009,3rd edition, ISBN 978-0-470-74168-9. 4- Pharmacognosy. Phytochemistry, medicinal plants. Bruneton Jean, Lavoisier; 2009 4th edition; ISBN 978- 2743011888. 1 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS PRIMARY AND SECONDARY METABOLISM All organisms need to transform and interconvert a vast number of organic compounds to enable them to live, grow, and reproduce. They need to provide themselves with energy in the form of ATP, and a supply of building blocks to construct their own tissues. An integrated network of enzyme-mediated and carefully regulated chemical reactions is used for this purpose, collectively referred to as intermediary metabolism, and the pathways involved are termed metabolic pathways. Despite the extremely varied characteristics of living organisms, the pathways for generally modifying and synthesizing carbohydrates, proteins, fats, and nucleic acids are found to be essentially the same in all organisms, apart from minor variations. These processes demonstrate the fundamental unity of all living matter, and are collectively described as primary metabolism. In contrast to these primary metabolic pathways, which synthesize, degrade, and generally interconvert compounds commonly encountered in all organisms, there also exists an area of metabolism concerned with compounds which have a much more limited distribution in nature. Such compounds, called secondary metabolites, are found in only specific organisms, or groups of organisms, and are an expression of the individuality of species. Secondary metabolites are not necessarily produced under all conditions, and in the vast majority of cases the function of these compounds and their benefit to the organism are not yet known. Some are undoubtedly produced for easily 2 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS appreciated reasons, e.g. as toxic materials providing defense against predators, as volatile attractants towards the same or other species, or as colouring agents to attract or warn other species, but it is logical to assume that all do play some vital role for the well-being of the producer. It is this area of secondary metabolism which provides most of the pharmacologically active natural products. It is thus fairly obvious that the human diet could be both unpalatable and remarkably dangerous if all plants, animals, and fungi produced the same range of compounds. Figure 1.1: Origins of secondary metabolites in relation to the basic metabolic pathways of plants 3 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS THE MEVALONATE AND METHYLERYTHRITOL PHOSPHATE PATHWAYS 1. TERPENOIDS Terpenoids comprise the largest group of natural products, with over 35000 known members. Terpenoids form a large and structurally diverse family of natural products derived from C5 isoprene units (Figure 1.2) joined in a head-to-tail fashion. Typical structures contain carbon skeletons represented by (C5)n, and are classified as hemiterpenes (C5), monoterpenes (C10), sesquiterpenes (C15), diterpenes (C20), sesterterpenes (C25), triterpenes (C30), and tetraterpenes (C40). Figure 1.2: Isoprene structure. 4 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS Figure 1.3: Terpenoids derivatives. Isoprene itself was known as a decomposition product from various natural cyclic hydrocarbons, and had been suggested as the fundamental building block for Terpenoids, also referred to as ‘isoprenoids„. 5 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS methyl-erythrol-4-phosphate, MEP -2 Figure 1.4: Isporene bio-origin. The biochemically active isoprene units were subsequently identified as the diphosphate (pyrophosphate) esters dimethylallyl diphosphate (DMAPP) and isopentenyl diphosphate (IPP) (Figure 1.5). O P P O P P I PP D M A PP Figure 1.5: active isoprene forms Isoprenoid synthesis then proceeds by the condensation of isopentenyl pyrophosphate with the isomeric dimethylallyl pyrophosphate to yield geranyl pyrophosphate. Further C5 units are added by the addition of more isopentenyl pyrophosphate. 6 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS Figure 1.6: Preliminary stages in the biosynthesis of isoprenoid compounds. Figure 1.7: Terpenoid derivatives of linear combination of isoprene units. Relatively few of the natural terpenoids conform exactly to the simple concept of a linear head-to-tail combination of isoprene units as seen with geraniol (C10), farnesol (C15), and geranylgeraniol (C20) (Figure 1.6). Squalene (C30) andphytoene (C40), although formed entirely of isoprene units, display a tail-to-tail linkage at the centre of the molecules. Most terpenoids are modified further by cyclization reactions. 7 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS Many other natural products contain terpenoid elements in their molecules, in combination with carbon skeletons derived from other sources, such as the acetate and shikimate pathways. Many alkaloids, phenolics, and vitamins are examples of this. 1.1. MONOTERPENES (C10) Enzyme-catalysed combination of DMAPP and IPP yields geranyl diphosphate (GPP). Figure 1.8: Geranyl diphosphate synthesis GPP and its isomers (Linalyl PP and neryl PP), by relatively modest changes, can give rise to a range of linear monoterpenes found as components of volatile oils used in flavouring and perfumery. The resulting compounds may be hydrocarbons, alcohols, aldehydes, or perhaps esters. Figure 1.9: Simple Monoterpenes formation 8 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS The range of monoterpenes encountered is extended considerably by cyclization reactions, and monocyclic or bicyclic systems can be created. Figure 1.10: monocyclic or bicyclic monoterpenes 1.1.1. IRIDOIDS (C10) The iridane skeleton (Figure 1.11), found in iridoids, is monoterpenoid in origin and contains a cyclopentane ring which is usually fused to a six-membered oxygen heterocycle. The iridoid system arises from geraniol by a type of folding. Iridane Iridoids Geraniol Figure 1.11: Iridane skeleton and iridoid based structure. The name derives from Iridomyrmex, a genus of ants which produces these compounds as a defensive secretion . Most occur as glycosides; some occur free and as bis compounds; Of pharmaceutical significance is their presence in Valerian, Gentian and Harpagophytum. 9 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS 1.1.1.1. GENTIAN, Gentiana lutea L. Gentian (Gentian Root BP, EP, BHP) consists of the dried fermented rhizomes and roots of the yellow gentian, Gentiana lutea L. (Gentianaceae). - Description: Gentian is a perennial herb about 1m high found in the mountainous districts of central and southern Europe and Turkey. Important districts for its collection are the Pyrenees, the Jura and Vosges Mountains, the Black Forest and former Yugoslavia. - Collection and preparation: When the plants are 2–5 years old, the turf is carefully stripped around each and the rhizomes and roots are dug up. This usually takes place from May to October, collection in the autumn being more difficult on account of the hardness of the soil, although possibly preferable from the medicinal point of view. The commercial drug consisting of ‘red„ or fermented gentian; Usually, the drug is made into heaps, which are allowed to lie on the hillside for some time and may even be covered with earth. After it is washed and cut into suitable lengths the drug is dried, first in the open air and then in sheds. Prepared in this way the drug becomes much darker in colour, loses some of its bitterness and acquires a very distinctive odour. - Constituents: Gentian contains bitter glycosides, alkaloids, yellow colouring matters, sugars, pectin and fixed oil. The secoiridoid gentiopicroside (about 2%, also known as gentiopicrin and gentiamarin). 11 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS The yellow colour of fermented gentian root is due to xanthones. - Uses: Gentian is used as a bitter tonic, it is also reported to have choleretic, antioxidative and hepatoprotective. In traditional medicine it has been employed to treat various gastrointestinal conditions, as an anti-inflammatory and wound- healing agent. Figure 1.12: Gentiana lutea 1.1.1.2. VALERIAN ROOT Valerian consists of the rhizome, stolons and roots of Valeriana officinalis L.s.l. (Valerianaceae), collected in the autumn and dried at a temperature below 40°C. - Description: The plant is a perennial about 1–2 m high. It is obtained from wild and cultivated plants in The Netherlands, Belgium, France, Germany, eastern Europe and Japan. It is also cultivated in the USA. 11 Dr. Dima MUHAMMAD PHYTOCHEMISTRY & NATURAL PRODUCTS Figure 1.13: Valeriana officinalis - Constituents: The drug yields about 0.5–1.0% of volatile oil, sesquiterpen derivatives (valerenic acid derivatives), in addition to epoxy-iridoid esters called valepotriates. Seasonal variations in the constituents of valerian raised in the Netherlands have been reported. Thus the accumulation of valerenic acid and its derivatives together with valepotriates reached a maximum in February to March whereas the volatile oil remained essentially constant during the period of study. H O, air, 2 tº>41 ºC Figure 1.14: Valerian roots constituents.
Recommended publications
  • CHRONIC NON PALLIATIVE PAIN (> 6 Months)
    CHRONIC NON PALLIATIVE PAIN (> 6 months) IN ADULTS – Primary Care Treatment Pathway Please note that this pathway is currently under review following publication of NICE guideline [NG193] - Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain (April 2021): https://www.nice.org.uk/guidance/ng193. Initial Assessment • Exclude serious pathology / red flags (investigate / refer as necessary). • Investigate and manage any underlying condition. • Determine pain type - nociceptive, mixed, neuropathic. Typical features of neuropathic pain: burning, shooting, allodynia, hyperalgesia, unpredictable, abnormal sensations. • Determine baseline severity of pain & functional impact. Use visual analogue or numerical rating scales (pain scales available from the British Pain Society). • If musculoskeletal pain offer manual therapy in addition to or instead of analgesics if appropriate. • Explore use of non-drug options e.g. psychological therapy and physical intervention therapies. Consider early specialis t referral • Where pain is severe or not responding to management. • Patients considered at increased risk of poor outcomes. For back pain consider use of Keele STarT Back Tool. Before prescribing • Determine use of over-the-counter (OTC) treatments / complemen tary therapies. • Offer British Pain Society leaflet https://www.britishpainsociety.org/static/upload s/resources/files/patient_pub_otc.pdf • Agree and document achievable pain goal e.g. 50% reduction in pain, improved function. • Advise on risks/benefits of medication, regime and target dose . • Avoid effervescent preparations, particularly with hypertension (due to salt content). • Prescribe single-constituent analgesics where appropriate, to allow independent titration of each drug. • Avoid low dose compound analgesics (e.g. co-codamol 8/500 mg and co-dydramol 10/500 mg).
    [Show full text]
  • The Cyanogenic Polymorphism in Trifolium Repens L
    Heredity66 (1991) 105—115 Received 16 May 1990 Genetical Society of Great Britain The cyanogenic polymorphism in Trifolium repens L. (white clover) M. A. HUGHES Department of Biochemistry and Genetics, The Medical School, The University, Newcastle upon Tyne NE2 4HH Thecyanogenic polymorphism in white clover is controlled by alleles of two independently segregating loci. Biochemical studies have shown that non-functional alleles of the Ac locus, which controls the level of cyanoglucoside produced in leaf tissue, result in the loss of several steps in the biosynthetic pathway. Alleles of the Li locus control the synthesis of the hydrolytic enzyme, linamarase, which is responsible for HCN release following tissue damage. Studies on the selective forces and the distribution of the cyanogenic morphs of white clover are discussed in relation to the quantitative variation in cyanogenesis revealed by biochemical studies. Molecular studies reveal considerable restriction fragment length polymorphism for linamarase homologous genes. Keywords:cyanogenesis,polymorphism, Trifolium repen, white clover. genetics to plant taxomony. This review discusses the Introduction extensive and diverse ecological genetic studies in rela- Theterm cyanogenesis describes the release of hydro- tion to the more recent biochemical and molecular cyanic acid (HCN), which occurs when the tissues of studies of cyanogenesis in white clover. some plant species are damaged. The first report of cyanogenesis in Trifolium repens (white clover) was by Mirande (1912) and this was shortly followed by a Biochemistry paper which demonstrated that the species was poly- Theproduction of HCN by higher plants depends morphic for the character, with both cyanogenic and upon the co-occurrence of a cyanogenic glycoside and acyanogenic plants occurring in the same population catabolic enzymes.
    [Show full text]
  • Chronic Cassava Toxicity
    4/63 7L ARCHIV NESTEL C-010e 26528 II Chronic Cassava Toxicity Proceedings of an interdisciplinary workshop London, England, 29-30 January 1973 Editors: Barry Nestel and Reginald Maclntyre INTERNATIONAL CENTRE DE RECHERCHES DEVELOPMENT POUR LE DEVELOPPEMENT RESEARCH CENTRE INTERNATIONAL Oawa, Canada 1973 IDRC-OlOe CHRONIC CASSAVA TOXICITY Proceedings of an interdisciplinary workshop London, England, 29-30 January 1973 Editors: BARRY NESTEL AND REGINALD MACINTYRE 008817 UDC: 615.9:547.49 633.68 © 1973 International Development Research Centre Head Office: Box 8500, Ottawa, Canada. K1G 3H9 Microfiche Edition S 1 Contents Foreword Barry Nestel 5-7 Workshop Participants 8-10 Current utilization and future potential for cassava Barry Nestel 11-26 Cassava as food: toxicity and technology D. G. Coursey 27-36 Cyanide toxicity in relation to the cassava research program of CIAT in Colombia James H. Cock 37-40 Cyanide toxicity and cassava research at the International Institute of Tropical Agriculture, Ibadan, Nigeria Sidki Sadik and Sang Ki Hahn 41-42 The cyanogenic character of cassava (Manihor esculenta) G. H. de Bruijn 43-48 The genetics of cyanogenesis Monica A. Hughes 49-54 Cyanogenic glycosides: their occurrence, biosynthesis, and function Eric E. Conn 55-63 Physiological and genetic aspects of cyanogenesis in cassava and other plants G. W. Butler, P. F. Reay, and B. A. Tapper 65-71 Biosynthesis of cyanogenic glucosides in cassava (Manihot spp.) Frederick Nartey 73-87 Assay methods for hydrocyanic acid in plant tissues and their application in studies of cyanogenic glycosides in Manihot esculenta A. Zitnak 89-96 The mode of cyanide detoxication 0.
    [Show full text]
  • Analgesic Policy
    AMG 4pp cvr print 09 8/4/10 12:21 AM Page 1 Mid-Western Regional Hospitals Complex St. Camillus and St. Ita’s Hospitals ANALGESIC POLICY First Edition Issued 2009 AMG 4pp cvr print 09 8/4/10 12:21 AM Page 2 Pain is what the patient says it is AMG-Ch1 P3005 3/11/09 3:55 PM Page 1 CONTENTS page INTRODUCTION 3 1. ANALGESIA AND ADULT ACUTE AND CHRONIC PAIN 4 2. ANALGESIA AND PAEDIATRIC PAIN 31 3. ANALGESIA AND CANCER PAIN 57 4. ANALGESIA IN THE ELDERLY 67 5. ANALGESIA AND RENAL FAILURE 69 6. ANALGESIA AND LIVER FAILURE 76 1 AMG-Ch1 P3005 3/11/09 3:55 PM Page 2 CONTACTS Professor Dominic Harmon (Pain Medicine Consultant), bleep 236, ext 2774. Pain Medicine Registrar contact ext 2591 for bleep number. CNS in Pain bleep 330 or 428. Palliative Care Medical Team *7569 (Milford Hospice). CNS in Palliative Care bleeps 168, 167, 254. Pharmacy ext 2337. 2 AMG-Ch1 P3005 3/11/09 3:55 PM Page 3 INTRODUCTION ANALGESIC POLICY ‘Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage’ [IASP Definition]. Tolerance to pain varies between individuals and can be affected by a number of factors. Factors that lower pain tolerance include insomnia, anxiety, fear, isolation, depression and boredom. Treatment of pain is dependent on its cause, type (musculoskeletal, visceral or neuropathic), duration (acute or chronic) and severity. Acute pain which is poorly managed initially can degenerate into chronic pain which is often more difficult to manage.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tuberculosis
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tuberculosis Chemical Activity Count (+)-3-HYDROXY-9-METHOXYPTEROCARPAN 1 (+)-8HYDROXYCALAMENENE 1 (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 3 (+)-AROMOLINE 1 (+)-CASSYTHICINE 1 (+)-CATECHIN 10 (+)-CATECHIN-7-O-GALLATE 1 (+)-CATECHOL 1 (+)-CEPHARANTHINE 1 (+)-CYANIDANOL-3 1 (+)-EPIPINORESINOL 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALBACIN 2 (+)-GALLOCATECHIN 3 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 2 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 2 (+)-T-CADINOL 1 (+)-VESTITONE 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-3-HYDROXY-9-METHOXYPTEROCARPAN 1 (-)-ACANTHOCARPAN 1 (-)-ALPHA-BISABOLOL 2 (-)-ALPHA-HYDRASTINE 1 Chemical Activity Count (-)-APIOCARPIN 1 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-CANESCACARPIN 1 (-)-CENTROLOBINE 1 (-)-CLANDESTACARPIN 1 (-)-CRISTACARPIN 1 (-)-DEMETHYLMEDICARPIN 1 (-)-DICENTRINE 1 (-)-DOLICHIN-A 1 (-)-DOLICHIN-B 1 (-)-EPIAFZELECHIN 2 (-)-EPICATECHIN 6 (-)-EPICATECHIN-3-O-GALLATE 2 (-)-EPICATECHIN-GALLATE 1 (-)-EPIGALLOCATECHIN 4 (-)-EPIGALLOCATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN-GALLATE 9 (-)-EUDESMIN 1 (-)-GLYCEOCARPIN 1 (-)-GLYCEOFURAN 1 (-)-GLYCEOLLIN-I 1 (-)-GLYCEOLLIN-II 1 2 Chemical Activity Count (-)-GLYCEOLLIN-III 1 (-)-GLYCEOLLIN-IV 1 (-)-GLYCINOL 1 (-)-HYDROXYJASMONIC-ACID 1 (-)-ISOSATIVAN 1 (-)-JASMONIC-ACID 1 (-)-KAUR-16-EN-19-OIC-ACID 1 (-)-MEDICARPIN 1 (-)-VESTITOL 1 (-)-VESTITONE 1
    [Show full text]
  • The Role of Phytotoxic and Antimicrobial Compounds of Euphorbia Gummifera in the Cause and Maintenance of the Fairy Circles of Namibia
    The role of phytotoxic and antimicrobial compounds of Euphorbia gummifera in the cause and maintenance of the fairy circles of Namibia by Nicole Galt Submitted in partial fulfillment of the requirements for the degree Magister Scientiae Department of Plant and Soil Sciences Faculty of Natural and Agricultural Sciences University of Pretoria Pretoria Supervisor: Prof. J.J.M. Meyer March 2018 i The role of phytotoxic and antimicrobial compounds of Euphorbia gummifera in the cause and maintenance of the fairy circles of Namibia by Nicole Galt Department of Plant and Soil Sciences Faculty of Natural and Agricultural Sciences University of Pretoria Pretoria Supervisor: Prof. J.J.M. Meyer Degree: MSc Medicinal Plant Science Abstract Fairy circles (FC) are unexplained botanical phenomena of the pro-Namib desert and parts of the West Coast of South Africa. They are defined as circular to oval shaped anomalies of varying sizes that are left bereft of vegetation. Even though there are several distinctly different hypotheses that have aimed to explain the origin of fairy circles, none have done so to satisfaction of the scientific community. The aim of this study was to determine if phytotoxic and antibacterial properties of a co-occurring Euphorbia species, E. gummifera plays a role in the creation of fairy circles. Representative soil samples (from inside-, outside fairy circles and underneath dead E. gummifera plants) and plant samples (aerial ii parts of E. gummifera and intact grasses, Stipagrostis uniplumis) were collected from the area. The collected samples were used for a several biological assays. A soil bed bio-assay was done using the three collected soil types.
    [Show full text]
  • Compound Analgesic)
    Bex (compound analgesic) Bex was a strong compound analgesic which was popular in Australia for much of the twentieth century. It came in the form of APC (aspirinâ“phenacetinâ“caffeine) tablets or powder, containing 42% aspirin, 42% phenacetin, plus caffeine. Bex was a product of Beckers Pty Ltd., originally based at Pym Street, Dudley Park, South Australia, but which relocated to Sydney in the 1960s. It was advertised with the phrase, "Stressful Day? What you need is a cup of tea, a Bex and a good lie down". Bex was a strong compound analgesic which was popular in Australia for much of the twentieth century. It came in the form of APC tablets or powder, containing 42% aspirin, 42% phenacetin, plus caffeine.[1]. For faster navigation, this Iframe is preloading the Wikiwand page for Bex (compound analgesic). Home. News. Bex (compound analgesic) Bex was a strong compound analgesic which was popular in Australia for much of the twentieth century. It came in the form of APC (aspirinâ“phenacetinâ“caffeine) tablets or powder, containing 42% aspirin, 42% phenacetin, plus caffeine.[1] Bex was a product of Beckers Pty Ltd., originally based at Pym Street, Dudley Park, South Australia,[2] but which relocated to Sydney in the 1960s.[3] It was advertised with the phrase, "Stressful Day? What you need is a cup of tea, a Bex and a good lie. Compound analgesics are those with multiple active ingredients; they include many of the stronger prescription analgesics. Active ingredients that have been commonly used in compound analgesics include: aspirin or ibuprofen.
    [Show full text]
  • The Response of Cyanogenic and Acyanogenic Phenotypes of Trifolium Repens to Soil Moisture Supply W
    THE RESPONSE OF CYANOGENIC AND ACYANOGENIC PHENOTYPES OF TRIFOLIUM REPENS TO SOIL MOISTURE SUPPLY W. FOULDS Science Department, Dudley CollegeofEducation and J. P. GRIME DepartmentofBotany, University of Sheffield Received14.vi.71 I. INTRODUCTION THE legumes Trjfolium repens L. and LotuscorniculatusL. are represented in many parts of the world by populations in which some or all of the plants are capable of releasing hydrocyanic acid under certain conditions. For both species, there is evidence (Barber, 1955; Jones, 1962) that cyanogenic individuals are less susceptible to grazing by small herbivores. Cyanogenesis is determined by two independent genes designated Ac and Li (Corkill, 1942; Atwood and Sullivan, 1943). The gene Ac is dominant and is responsible for the production of two cyanogenic glucosides, lotaus- tralin and linamarin, which occur in the proportion 4 : 1 (Melville and Doak, 1940). Modifying genes determine the quantity of glucoside produced (Corkill, 1940). The cyanogenic glucosides can be hydrolysed by the - glucosidase,linamarase (Coop, 1940) the production of which is governed by the dominant gene Li. Hydrolysis yields acetone (from linamarin), methyl-ethyl-ketone (from lotaustralin), glucose, hydrogen cyanide and water. Hughes (1968) maintains that two -glucosidases occur in Trjfolium repens, one, linamarase of high activity, the other of low activity. Corkill (1940) showed that individual plants may contain both enzyme and glucoside (AcLi), enzyme only (acLi), glucoside only (Acli) or neither (acli). Daday (1954a, b, 1958) measured the contribution of each of the four phenotypes to populations of Trfo1ium repens sampled on a world scale and found that high frequencies of both Ac and Li genes were associated with warm winter conditions.
    [Show full text]
  • PHYSIOLOGICAL STUDIES on the CYANOGENIC GLUCOSIDES in LOTUS ARABICUS L. Very Little Work Relating to the Physiological Studies O
    PHYSIOLOGICAL STUDIES ON THE CYANOGENIC GLUCOSIDES IN LOTUS ARABICUS L. YASH PAL ABROL Division of I!lant Physiology and Phytotron, Indian A,£;ricultural Research Institute, Delhi-12 SuMMARY Observations on the occurrence of cyanogenic glucosides, linamarin and lotaustralin, in Lotus arabicus L., are reported. During the vegetative stage, a major portion of the cyanogens is localised in the leaves. With the onset of flowering, cyanogen content on per plant basis shows a sharp decrease but flower buds and flowers have a high content. Experiments on feeding carbon-14 labelled L-valine and L-isoleucine to flower buds reveals that the compounds are synthesised in these parts. lYiature seeds do not contain any detectable amounts of the cyanogens. I:-!TRODUCTION Very little work relating to the physiological studies on cyanogenic glucosides in higher plants has been reported. This is very likely due to the predominant view held until recently that a very small number of plants are cyanophoric and that cyano­ genic glucosides are inert end products of metabolism (Robinson, 1930). Work of physiological nature is however of interest in view of the recent observations that cyanogenic glucosidcs arc widely distributed (Dilleman, 1958; Hegnaucr, 1964), HCN is metabolised by seedlings of cyanophoric as well as non-cyano­ phoric plants (Blumenthal-Goldschmidt, Butler and Conn, 1963 Tschiersch, 1964; Nigam and Ressler, 1964), cyanogenic gluco­ sides are metabolically active rather than inert end products (Abrol, Uribe and Conn, 1965; Abrol and Conn, 1966; Abrol, Conn and Stoker, 1966) and are very likely involved in the synthesis of various neurotoxic and neurolathvritic amino acids (Ressler, 1962 ; Tschiersch, 1964).
    [Show full text]
  • Central Nervous System 4.1 Hypnotics and Anxiolytics
    BNF CHAPTER 4: CENTRAL NERVOUS SYSTEM Link to: CWP Mental Health Formulary 4.1 HYPNOTICS AND ANXIOLYTICS Benzodiazepine prescribing guidelines Benzodiazepines must not be prescribed routinely. Benzodiazepines must not be prescribed for more than 10 nights as a hypnotic or as an anxiolytic for more than 4 weeks. Apart from chronic users, patients should generally not be discharged from hospital taking a benzodiazepine. An example of where it may be appropriate includes patients receiving palliative care. Can be difficult to withdraw benzodiazepines if they have been taken regularly for more than a few weeks. 4.1.1 HYPNOTICS Temazepam 10mg tablets 10mg/5mL elixir Temazepam for ward stock must be ordered using the Controlled Drug order book. Zopiclone 3.75mg, 7.5mg tablets Hypnotics should only be prescribed for short term use. Patients requiring hypnotics in hospital should have them prescribed on the PRN side of the prescription chart. Such patients will not have hypnotics prescribed to them on discharge. It is recommended that, because of the lack of compelling evidence to distinguish between zopiclone or the shorter acting benzodiazepine hypnotics, the drug with the lowest purchase cost (taking into account daily required dose and product price per dose) should be prescribed. (NICE Technology Appraisal No 77). Temazepam is therefore the preferred option for all patients on the basis of cost. However, in the Trust, zopiclone may be considered for first line use as it is not subject to internal controlled drug restrictions. Joint
    [Show full text]
  • CYP79A118 Is Associated with the Formation of Taxiphyllin in Taxus Baccata
    Plant Mol Biol (2017) 95:169–180 DOI 10.1007/s11103-017-0646-0 CYP79 P450 monooxygenases in gymnosperms: CYP79A118 is associated with the formation of taxiphyllin in Taxus baccata Katrin Luck1 · Qidong Jia2 · Meret Huber1 · Vinzenz Handrick1,3 · Gane Ka‑Shu Wong4,5,6 · David R. Nelson7 · Feng Chen2,8 · Jonathan Gershenzon1 · Tobias G. Köllner1 Received: 1 March 2017 / Accepted: 2 August 2017 / Published online: 9 August 2017 © The Author(s) 2017. This article is an open access publication Abstract plant divisions containing cyanogenic glycoside-producing Key message Conifers contain P450 enzymes from the plants has not been reported so far. We screened the tran- CYP79 family that are involved in cyanogenic glycoside scriptomes of 72 conifer species to identify putative CYP79 biosynthesis. genes in this plant division. From the seven resulting full- Abstract Cyanogenic glycosides are secondary plant com- length genes, CYP79A118 from European yew (Taxus bac- pounds that are widespread in the plant kingdom. Their bio- cata) was chosen for further characterization. Recombinant synthesis starts with the conversion of aromatic or aliphatic CYP79A118 produced in yeast was able to convert L-tyros- amino acids into their respective aldoximes, catalysed by ine, L-tryptophan, and L-phenylalanine into p-hydroxyphe- N-hydroxylating cytochrome P450 monooxygenases (CYP) nylacetaldoxime, indole-3-acetaldoxime, and phenylacetal- of the CYP79 family. While CYP79s are well known in doxime, respectively. However, the kinetic parameters of the angiosperms, their occurrence in gymnosperms and other enzyme and transient expression of CYP79A118 in Nico- tiana benthamiana indicate that L-tyrosine is the preferred Accession numbers Sequence data for genes in this article substrate in vivo.
    [Show full text]
  • Cobrotoxin-Containing Analgesic Compound to Treat Chronic
    1077-1084 6/10/06 16:33 Page 1077 ONCOLOGY REPORTS 16: 1077-1084, 2006 Cobrotoxin-containing analgesic compound to treat chronic moderate to severe cancer pain: Results from a randomized, double-blind, cross-over study and from an open-label study J.M. XU1, S.T. SONG1, F.Y. FENG2, F.L. HUANG3, Y. YANG4, G.R. XIE5, L.G. XU6, C.Z. ZHANG7, M. BRUNO8 and A. PARADISO8 1Beijing 307 Hospital Cancer Center; 2Cancer Hospital, Chinese Academy of Medical Sciences, Beijing; 3Jiangsu Province Cancer Hospital, Nanjing; 4Kunming the PLA General Hospital, Kunming; 5Tianjin Cancer Hospital, Tianjin; 6Cancer Hospital, Fudan University, Shanghai; 7The Third Teaching Hospital, Kunming Medical University, Kunming, P.R. China; 8National Cancer Institute, Bari, Italy Received June 5, 2006; Accepted July 19, 2006 Abstract. Cobrotoxin produces intense analgesia but it has satisfactory pain relief. Pain response was classified as CR, an onset of response of 1-3 h which hampers its clinical use PR and NC. CR was defined as 100% pain relief, with a pain in cancer pain. Recently, a compound analgesic formulation score of 0 on a 0-10 VAS. PR was defined as decreased to combining cobrotoxin, tramadol hydrochloride and ibuprofen mild pain, with a pain score of no more than 4 on a 0-10 VAS. (Compound Keluoqu, CKLQ) has become available in China. NC was defined as pain that either remained unchanged or The aim of this study was to evaluate the clinical efficacy of that was reduced from severe to moderate at baseline, with a CKLQ for moderate to severe cancer pain.
    [Show full text]